Skip to main content
. 2015 Dec 23;10(12):e0144019. doi: 10.1371/journal.pone.0144019

Table 6. Patient characteristics.

Pt No Gender Age Tumor Number of nodules Total nodules diameter (cm) FLR (mL) before and after ALPPS1 FLR (%) before and after ALPPS1 FLR Increase(%) Liver Resection (segments) Hospital status Status Follow-up (months)
1 F 54 pCCA 1 NA 318/665 24/30 109 1-4-5-6-7-8 29 Alive 29,53
2 F 66 iCCA 2 10 393/566 27/34 44 1-4-5-6-7-8 27 Alive 24,23
3 F 69 CRLM 1 11 174/348 22/33 100 1-4-5-6-7-8 16 Alive 23,57
4 F 60 pCCA 1 NA 208/540 15/36 160 1-4-5-6-7-8 15 Alive 19,89
5 F 49 HCC 1 14 552/684 25/24 24 4-5-6-7-8 23 Alive 17,13
6 F 73 pCCA 1 NA 192/395 16/24 105 1-4-5-6-7-8 15 Dead 0,69
7 M 53 CRLM 4 9.5 194/502 14/35 159 4b-5-6-7-8 24 Alive 13,21
8 M 62 CRLM 1 5 304/632 18/32 108 4-5-6-7-8 26 Alive 13,21
9 F 54 CRLM 4 9.7 270/421 29/42 56 4-5-6-7-8 56 Alive 12,26

pCCA = perihilar cholangiocarcinoma; iCCA = Intrahepatic cholangiocarcinoma; CRLM: Colorectal liver metastases; HCC = Hepatocellular carcinoma. NA: not applicable.